Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy

Verfasser / Beitragende:
[Imari Deura, Muneaki Shimada, Keiko Hirashita, Maki Sugimura, Seiya Sato, Shinya Sato, Tetsuro Oishi, Hiroaki Itamochi, Tasuku Harada, Junzo Kigawa]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/3(2015-06-01), 556-560
Format:
Artikel (online)
ID: 605491070
LEADER caa a22 4500
001 605491070
003 CHVBK
005 20210128100508.0
007 cr unu---uuuuu
008 210128e20150601xx s 000 0 eng
024 7 0 |a 10.1007/s10147-014-0724-0  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-014-0724-0 
245 0 0 |a Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy  |h [Elektronische Daten]  |c [Imari Deura, Muneaki Shimada, Keiko Hirashita, Maki Sugimura, Seiya Sato, Shinya Sato, Tetsuro Oishi, Hiroaki Itamochi, Tasuku Harada, Junzo Kigawa] 
520 3 |a Abstract : Background: Lower limb lymphedema (LLL) is one of the most frequent postoperative complications of retroperitoneal lymphadenectomy for gynecologic cancer. LLL often impairs quality of life, activities of daily living, sleep, and sex in patients with gynecologic cancer. We conducted this study to evaluate the incidence and risk factors for LLL after gynecologic cancer surgery in patients who received assessment and periodic complex decongestive physiotherapy (CDP). Methods: We retrospectively reviewed 126 cases of gynecologic cancer that underwent surgery involving retroperitoneal lymphadenectomy at Tottori University Hospital between 2009 and 2012. All patients received physical examinations to detect LLL and underwent CDP by nurse specialists within several months after surgery. The International Society of Lymphology staging of lymphedema severity was used as the diagnostic criteria. Results: Of 126 patients, 57 (45.2%) had LLL, comprising 45 and 12 patients with stage 1 and stage 2 LLL, respectively. No patient had stage 3 LLL. LLL was present in 37 (29.4%) patients at the initial physical examination. Multivariate analysis revealed that adjuvant concurrent chemoradiotherapy and age ≥55years were independent risk factors for ≥stage 2 LLL. Conclusions: To minimize the incidence of ≥stage 2 LLL, gynecologic oncologists should be vigilant for this condition in patients who are ≥55years and in those who undergo adjuvant chemoradiotherapy. Patients should be advised to have a physical assessment for LLL and to receive education about CDP immediately after surgery involving retroperitoneal lymphadenectomy for gynecologic cancer. 
540 |a Japan Society of Clinical Oncology, 2014 
690 7 |a Lower limb lymphedema  |2 nationallicence 
690 7 |a Gynecologic cancer  |2 nationallicence 
690 7 |a Lymphadenectomy  |2 nationallicence 
690 7 |a Complex decongestive physiotherapy  |2 nationallicence 
700 1 |a Deura  |D Imari  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Shimada  |D Muneaki  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Hirashita  |D Keiko  |u Department of Nursing, Tottori University Hospital, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Sugimura  |D Maki  |u Department of Nursing, Tottori University Hospital, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Sato  |D Seiya  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Sato  |D Shinya  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Oishi  |D Tetsuro  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Itamochi  |D Hiroaki  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Harada  |D Tasuku  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
700 1 |a Kigawa  |D Junzo  |u Matsue City Hospital, 32-1 Noshiro-cho, 690-8508, Matsue, Japan  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/3(2015-06-01), 556-560  |x 1341-9625  |q 20:3<556  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-014-0724-0  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-014-0724-0  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Deura  |D Imari  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shimada  |D Muneaki  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hirashita  |D Keiko  |u Department of Nursing, Tottori University Hospital, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sugimura  |D Maki  |u Department of Nursing, Tottori University Hospital, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sato  |D Seiya  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sato  |D Shinya  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Oishi  |D Tetsuro  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Itamochi  |D Hiroaki  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Harada  |D Tasuku  |u Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, 683-8504, Yonago, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kigawa  |D Junzo  |u Matsue City Hospital, 32-1 Noshiro-cho, 690-8508, Matsue, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/3(2015-06-01), 556-560  |x 1341-9625  |q 20:3<556  |1 2015  |2 20  |o 10147